Patients receiving Lumosa Therapeutics' stroke drug were not at an increased risk of experiencing a serious brain hemorrhage, meeting the main goal of a midstage study and setting up the small biotech ...

KALAMAZOO, Mich. — On average, someone in the United States has a stroke every 40 seconds, according to the American Heart Association. Tom Rowley, a 74-year-old West Michigan man, became a part of ...

University of Pittsburgh School of Medicine researchers report the final outcomes of a pioneering pilot clinical trial using ...

Preliminary research turns to a fully implantable system ...

Patients with noncardioembolic ischemic stroke or transient ischemic attack (TIA) are at risk for recurrent stroke. Low factor XI levels are associated with a reduced risk of ischemic stroke.

The effects of the glycoprotein IIb/IIIa receptor inhibitor tirofiban in patients with acute ischemic stroke but who have no evidence of complete occlusion of large or medium-sized vessels have not ...

Researchers at Washington University School of Medicine in St. Louis have found that safety interventions - such as walkers, grab bars, ramps and other home modifications - allow many stroke survivors ...

The Centers for Disease Control and Prevention (CDC) says that a preliminary COVID-19 vaccine "safety signal" has been identified and is investigating whether the Bivalent Pfizer-BioNTech vaccine ...

Ischemic stroke is a leading cause of death and disability in the Western world. At present, intravenous administration of tissue plasminogen activator within 3 h of symptom onset is the only proven ...